Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours

British Journal of Dermatology

Volumn 153, Issue 4, 2005, Pages 785-789

  Hinterhuber, Gabriele ^a   Cauza, K ^a   Dingelmaier Hovorka, R ^a   Diem, E ^a   Horvat, R ^a   Wolff, K ^a   Foedinger, D ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Actinic keratosis; Basal cell carcinoma; Retinol binding protein; RPE65; Squamous cell carcinoma

Indexed keywords

ANTIBODY; RETINOL BINDING PROTEIN; RPE65 ANTIBODY; RPE65 PROTEIN; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; DOWN-REGULATION; EYE PROTEINS; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOSIS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RETINOL-BINDING PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS;

EID: 26244461972     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06769.x     Document Type: Article

References (31)

1. Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer. Arch Dermatol 1997; 133:1263-70.
2. Alam M, Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med 2001; 344:975-83.
3. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (Suppl. 61):1-6.
4. Carucci JA, Leffell DJ. Basal cell carcinoma. In: Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds), 6th edn. New York: McGraw-Hill, 2003; 747-57.
5. Grossman D, Leffell DJ. Squamous cell carcinoma. In: Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds), 6th edn. New York: McGraw-Hill, 2003; 737-47.
6. Duncan KO, Leffell DJ. Epithelial precancerous lesions. In: Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds), 6th edn. New York: McGraw-Hill, 2003; 719-37.
7. Hinterhuber G, Cauza K, Brugger K et al. RPE65 of retinal pigment epithelium, a putative receptor molecule for plasma retinol binding protein, is expressed in human keratinocytes. J Invest Dermatol 2004; 122:406-13.
8. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrin Rev 1994; 15:61-79.
9. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10:940-54.
10. Fisher GJ, Voorhees JJ. Molecular mechanism of retinoid actions in skin. FASEB J 1996; 10:1002-13.
11. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996; 10:1031-9.
12. Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 1998; 39:562-6.
13. Kraemer KH, DiGiovanna JJ, Moshell AN et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318:1633-7.
14. Bavinck JN, Tieben LM, van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double blind, placebo-controlled study. J Clin Oncol 1995; 13:1933-8.
15. Levine N, Moon TE, Cartmel B et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 1997; 6:957-61.
16. Moon TE, Levine N, Cartmel B et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 1997; 6:949-56.
17. Goldberg LH, Hsu SH, Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol 1989; 21:144-5.
18. Tangrea JA, Edwards BK, Taylor PR et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst 1992; 84:328-32.
19. Redmond TM, Hamel CP. Genetic analysis of RPE65: from human disease to mouse model. Methods Enzymol 2000; 316:705-24.
20. Lippman SM, Kalvakolanu V, Lotan R. Retinoids and interferons in non-melanoma skin cancer. J Invest Dermatol Symp Proc 1996; 1:219-22.
21. Levine N, Miller RC, Meyskens FL Jr. Oral isotretinoin therapy: use in a patient with multiple cutaneous carcinomas and keratoacanthomas. Arch Dermatol 1984; 120:1215-17.
22. Lippman SM, Meyskens FL Jr. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 1987; 107:499-502.
23. Odom R. Managing actinic keratosis with retinoids. J Am Acad Dermatol 1998; 39:574-8.
24. Wang Z, Boudjelal M, Kang S et al. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med 1999; 5:418-22.
25. Darwiche N, Celli G, Tennenbaum T et al. Mouse skin tumor progression results in differential expression of retinoic acid and retinoic X receptors. Cancer Res 1995; 55:2774-82.
26. Xu XC, Wong WYL, Goldberg L et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 2001; 61:4306-10.
27. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP et al. Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000; 92:475-80.
28. Roberts D, Williams SJ, Cvetkovich D et al. Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. DNA Cell Biol 2002; 21:11-19.
29. Vahlquist A, Andersson E, Coble BI et al. Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carinoma and keratoacanthoma but not in basal cell carcinoma of the skin. J Invest Dermatol 1996; 106:1070-4.
30. Wahlberg P, Fex G, Wennerberg J. A relationship between retinol and cellular retinol-binding protein concentrations in human squamous cell carcinomas. Biochim Biophys Acta 1989; 1010:287-93.
31. Peris K, Fargnoli MC, Chimenti S. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N Engl J Med 1999; 341:1767-8.